Release Date: 25/10/12 11:08 Summary: Change of Director's Interest Notice Price Sensitive: No Download Document 285.65KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%